Anna Forbes

Focus Therapy Areas: Haematology, Immunology, Respiratory

Specialist Expertise: Cell Therapy, Immunotherapy, Beyond the Pill Strategy 

Education: BSc Biology, University of York; MPhil Therapeutic Sciences, University of Cambridge

What is your focus at Eradigm?

I conduct commercial opportunity assessments and competitive analyses to support our clients’ pipeline and product launch strategy. In my work, I focus on rigorous analysis and the identification of unique opportunities which lays the foundation for impactful recommendations and discussions around optimal next-steps. 

Who do you work with?

I collaborate with scientific and commercial teams across top 20 pharma companies, often drawing on conversations I’ve had with key opinion leaders to understand challenges and next-gen innovations to address these within the wider industry. 

What is your specialist expertise, and what types of projects do you work on?

I specialise in novel drug modalities including cell and antibody-based therapies. My growing project portfolio includes opportunity and gap assessments (Oncology), CI Monitoring (Respiratory) and Market Research (Immunology) projects. 

What did you do before Eradigm?

I previously worked at GSK and Merck KGaA, where I supported strategic partnerships and initiatives, and completed a short stint at Schlich Patent Attorneys. 

What are your passions outside of work?

I am interested in everything tech-related and enjoy running, baking and painting.